Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
10 tulemused
Strontium ranelate for the management of osteoporosis.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
OBJECTIVE
To evaluate the role of strontium ranelate in the management of osteoporosis.
METHODS
A MEDLINE (January 1966 to May 2007) search using the terms osteoporosis, strontium ranelate, bonemineral density, and fractures.
METHODS
All English-language articles identified from the data sources
Strontium ranelate for preventing and treating postmenopausal osteoporosis.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND
Strontium ranelate is a new anti-osteoporosis therapy therefore, its benefits and harms need to be known.
OBJECTIVE
To determine the efficacy and safety of strontium ranelate for the treatment and prevention of postmenopausal osteoporosis.
METHODS
We searched MEDLINE (1996 to March 2005),
[Strontium ranelate: a novel concept for the treatment of osteoporosis].
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The di-strontium salt strontium ranelate, a novel orally active agent consisting of two atoms of stable strontium and the organic moiety ranelic acid, has been developed for the treatment of osteoporosis. It has been shown to enhance osteoblastic cell replication and increase collagen synthesis
Strontium ranelate: a novel treatment for postmenopausal osteoporosis: a review of safety and efficacy.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Strontium ranelate is a new orally administered agent for the treatment of women with postmenopausal osteoporosis that reduces the risk of vertebral and hip fractures. Evidence for the safety and efficacy of strontium ranelate comes from two large multinational trials, the SOTI (Spinal Osteoporosis
Strontium ranelate--data on vertebral and nonvertebral fracture efficacy and safety: mechanism of action.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Strontium ranelate is a novel therapy for the treatment of postmenopausal osteoporosis with actions to reduce bone resorption and increase bone formation. In vitro, strontium ranelate has anabolic and antiresorptive activity, increasing collagen and non-collagen protein synthesis, enhancing
Strontium ranelate for preventing and treating postmenopausal osteoporosis.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND
Strontium ranelate is a new treatment for osteoporosis therefore, its benefits and harms need to be known.
OBJECTIVE
To determine the efficacy and safety of strontium ranelate for the treatment and prevention of postmenopausal osteoporosis.
METHODS
We searched MEDLINE (1996 to March
The palliation of osseous metastasis with 32P or 89Sr compared with external beam and hemibody irradiation: a historical perspective.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Radiation is an effective modality for palliation of osseous metastases. In patients with a limited number of lesions, local external beam irradiation is the most expedient method of delivering radiation therapy. Complete or partial relief of pain will occur in 80-90% of patients. When metastases
Crystal structure of the oligomerization domain of NSP4 from rotavirus reveals a core metal-binding site.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
During the maturation of rotaviral particles, non-structural protein 4 (NSP4) plays a critical role in the translocation of the immature capsid into the lumen of the endoplasmic reticulum. Full-length NSP4 and a 22 amino acid peptide (NSP4(114-135)) derived from this protein have been shown to
Adverse drug reactions to osteoporosis treatments.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Treatments for postmenopausal osteoporosis are generally safe, but are linked to some rare serious adverse drug reactions, for which causality is not always certain. The bisphosphonates are associated with gastrointestinal effects, acute phase reactions, and musculoskeletal pain, and, more rarely,
Hypocalciuria in overt and subclinical celiac disease.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
OBJECTIVE
To investigate indices of calcium (Ca) homeostasis in celiac disease (CD).
METHODS
Urinary Ca excretion rate, intestinal absorption of strontium (Sr) (used as index of intestinal Ca absorption), and other variables related to these end points were measured in newly diagnosed, untreated
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
